The Risk of Malignancy in Secukinumab-Treated Psoriasis, Psoriatic Arthritis, and Ankylosing Spondylitis Patients
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The British Journal of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
The Risk of Malignancy in Secukinumab-Treated Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis Patients: Analysis of Up to Five-Year Clinical Trial and Post-Marketing Surveillance Data
Br J Dermatol 2021 Apr 08;[EPub Ahead of Print], M Lebwohl, A Deodhar, CEM Griffiths, MA Menter, D Poddubnyy, W Bao, V Jehl, K Marfo, P Primatesta, A Shete, V Trivedi, PJ MeaseFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.